AL
Amrize Ltd (AMRZ)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 revenue was $3.22B, down 0.7% year over year; adjusted EBITDA was $947M with a 29.4% margin, reflecting resilient performance despite inclement weather and softer market volumes .
- Results included an incremental $42M in standalone corporate costs not in Q2 2024; excluding these, adjusted EBITDA margin would have been 30.7%, indicating stable underlying profitability in a softer volume environment .
- FY2025 financial targets were reiterated: revenue $11.4B–$11.8B, adjusted EBITDA $2.9B–$3.1B, and year-end net leverage under 1.5x, with assumptions of ~$700M CapEx, ~$850M D&A, and a 22–24% tax rate .
- Balance sheet established at investment grade (S&P BBB+, Moody’s Baa1), with $6.2B gross debt, $5.6B net debt, and 1.8x net leverage as of Q2; management expects <1.5x by year-end, supporting growth investments and shareholder returns .
What Went Well and What Went Wrong
What Went Well
- Stable consolidated margins: adjusted EBITDA margin of 29.4% despite lower volumes; excluding standalone corporate costs, margins were stable, highlighting disciplined pricing and efficiency .
- Building Materials segment maintained strong margin discipline (33.7%) supported by infrastructure demand and pricing actions, despite volume declines in cement (-6.3%) and aggregates (-2.9%) .
- Strategic execution on growth: launched ASPIRE program targeting $250M+ synergies through 2028 (~50 bps margin improvement annually), began incremental savings in H2 2025; continued CapEx/M&A including Ste. Genevieve expansion, St. Constant capacity, Langley acquisition, and new Oklahoma quarry .
What Went Wrong
- Year-over-year earnings compression: net income fell 9.5% to $428M and adjusted EBITDA declined 5.6% to $947M due to softer volumes and incremental standalone corporate costs .
- Residential market softness persisted, with higher interest rates limiting new construction and existing home sales; commercial uncertainty impacted timing of smaller projects and CapEx .
- Segment EBITDA modestly down: Building Materials (-1.6% YoY) and Building Envelope (-0.8% YoY), reflecting volume pressure and price-over-cost stability rather than expansion .
Financial Results
Consolidated Results vs Prior Quarter and Prior Year
EPS vs Prior Year and Current Quarter
Q2 2025 Actuals vs S&P Global Consensus
Values retrieved from S&P Global.*
Segment Breakdown (Q2 2025 vs Q2 2024)
KPIs (Q2 2025)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We successfully listed Amrize on the NYSE and SIX on June 23… generating stable revenue and strong margins… With an investment grade balance sheet and substantial financial firepower to fuel our growth, we are ready to deliver superior value to all stakeholders.” — Jan Jenisch, Chairman & CEO .
- ASPIRE program targets “more than $250 million in synergies through 2028, delivering over 50 basis points of margin improvement per year” with incremental savings beginning in H2 2025 and full annual run-rate in 2026 .
- Building Materials outlook driven by “infrastructure modernization, onshoring of manufacturing, data center expansion and the need to bridge the housing gap” .
- Building Envelope supported by acquisition (Ox Engineered Products contributed $33M revenue) and “disciplined pricing with stable price over cost” amid softer residential demand .
- Investment grade established: “S&P BBB+ and Moody’s Baa1… Gross Debt $6.2B… Net Leverage Ratio 1.8x… anticipate under 1.5x by year-end 2025” .
Q&A Highlights
- Pricing and margins: Management emphasized a 14th consecutive quarter of positive price over cost, supported by low-to-mid single-digit pricing and cost efficiencies; FX was a headwind in higher-profit countries .
- Guidance stance: FY2025 guidance left unchanged from March; management aims to “overachieve” within 6–10% recurring EBIT growth and sees H2 momentum equal to or better than H1 .
- Europe volumes: Expect flattish to modest improvement in H2 with margin expansion driven by sustainable offerings and decarbonization/circular construction .
- EU ETS and 2026 pricing: Too early to quantify, but likely higher price increases than 2025 as Phase 4 benchmarks/allowances evolve; monitoring CBAM/import dynamics .
- M&A cadence: Healthy pipeline across regions, strict discipline on bolt-ons; larger deal screening ongoing, focused on end-to-end solutions across walling, roofing, etc. .
Estimates Context
- Q2 2025 revenue missed S&P Global consensus ($3.22B actual vs $3.389B* estimate), and adjusted EBITDA missed ($0.947B actual vs $1.098B* estimate). EPS was $0.78, but consensus EPS was unavailable* .
- With incremental standalone corporate costs ($42M) and weather/macro headwinds, near-term consensus may need to reflect price-over-cost resilience but volume sensitivity in residential and timing effects in commercial .
Values retrieved from S&P Global.*
Key Takeaways for Investors
- Underlying margin resilience remains intact despite softer volumes; excluding $42M standalone corporate costs, Q2 margin would have been 30.7%, evidencing pricing discipline and cost efficiencies .
- Secular demand from infrastructure, data centers, and onshoring supports the Building Materials outlook; near-term residential remains rate-sensitive .
- FY2025 targets maintained and investment-grade balance sheet (1.8x leverage, <1.5x expected by year-end) provide capacity for growth CapEx and bolt-on M&A, supporting medium-term margin expansion via ASPIRE synergies .
- Segment trends: Building Materials margins stable on price discipline; Building Envelope steady with acquisition contribution ($33M) and price-over-cost management .
- Watch 2026 pricing in Europe (EU ETS Phase 4) and CBAM/import dynamics; management indicated potential for higher price increases in 2026 vs 2025 .
- Near-term trading: The double miss vs revenue and EBITDA consensus may weigh on sentiment; however, reaffirmed FY targets, synergy program catalysts, and investment-grade firepower are offsets for medium-term thesis .
- Execution milestones to monitor: H2 synergy savings start, Ste. Genevieve/St. Constant capacity additions, Malarkey shingle plant build, and continued bolt-ons to support consolidated margin trajectory .